Antibody News and Research

RSS

An antibody is a blood protein that is produced in response to and counteracts an antigen. Antibodies are produced in response to disease and help the body fight against the particular disease. In this way, antibodies help the body develop an immunity to disease.

How could SARS-CoV-2 viral infection modulate the immune landscape during the active infection phase and recovery in pregnant females?

Researchers examined immune reflexes towards SARS-CoV-2 infection among pregnant women.

24 Aug 2022

The safety, tolerability, and pharmacokinetics of a muco-trapping monoclonal antibody delivered by inhalation

Researchers conducted a phase I clinical trial of IN-006, an inhaled monoclonal antibody treatment for COVID-19.

24 Aug 2022

Updated guidelines on the Valneva SARS-CoV-2 vaccine

The WHO provides interim guidelines for the use of the Valneva vaccine.

23 Aug 2022

Epistasis leads to the reduction in genetic barrier to COVID-19 neutralizing antibody escape

A new study addresses the important question of how the SARS-CoV-2 virus would evolve in the future to be able to escape diverse and broadly neutralizing antibodies.

23 Aug 2022

DNA origami as an alternative platform to display the RBD of SARS-CoV-2

Researchers demonstrated DNA origami as a potential platform to display the SARS-CoV-2 receptor-binding domain.

23 Aug 2022

What risk factors are associated with post-acute sequelae of SARS-CoV-2?

Researchers explored the risk factors correlated with post-acute sequelae of SARS-CoV-2.

23 Aug 2022

What are the effects of anti-spike antibody levels on SARS-CoV-2 infection risk?

In a new study, researchers investigated the effect of anti-spike antibody levels on the risk of infection with SARS-CoV-2.

23 Aug 2022

The role of SARS-CoV-2 in COVID-19-associated chilblains

A recent study published in the British Journal of Dermatology evaluated COVID-19-associated chilblains.

23 Aug 2022

Many people infected with SARS-CoV-2 Omicron didn't realize it

A recent study reports on the awareness level among individuals during the recent Omicron variant surge.

22 Aug 2022

Study reveals safety and uptake of sotrovimab against severe SARS-CoV-2 infection in England

In a newly released study, researchers explored the sotrovimab uptake for severe COVID-19 prophylaxis and its safety across the community populations in England.

22 Aug 2022

How effective are nanotechnology-based vaccines, drugs, and antibodies to combat variants of SARS-CoV-2?

Researchers explored how effectively nanotechnology-based novel and potential vaccines, drugs, and monoclonal antibodies could combat the current and yet to emerge SARS-CoV-2 variants.

22 Aug 2022

Study shows rapid waning of immune protection due to prior BA.1/BA.2 infection against BA.5 breakthrough infection

Researchers investigated the waning of protective immunity conferred by prior infection by Omicron sub-variants BA.1, BA.2 towards its most recent sub-variant BA.5.

22 Aug 2022

Durability of immune protection after booster immunization with COVID-19 adjuvanted subunit vaccine against the immune-evasive Omicron BA.1 variant

Researchers explored the durability of immunity imparted by the SARS-CoV-2 adjuvanted subunit vaccine against the Omicron variant.

22 Aug 2022

How natural alterations inside the SARS-CoV-2 glycan barrier affect spike protein dynamics

Researchers explored how the natural alterations inside the SARS-CoV-2 glycan barrier affect the spike protein dynamics.

22 Aug 2022

Human antibody responses to SARS-CoV-2 infection after two years

Scientists describe a protocol to evaluate antibody response dynamics up to two years following SARS-CoV-2 infection.

21 Aug 2022

Researchers investigate human monkeypox infection without sexual exposure or viral prodrome

In a new study, researchers investigated a case of human monkeypox infection without sexual exposure or viral prodrome.

19 Aug 2022

How do BNT162b2 vaccine-induced neutralizing and non-neutralizing antibodies synergize to promote protection against SARS-CoV-2?

Scientists explored the COVID-19 BNT162b2 vaccine triggered non-neutralizing and neutralizing antibody functions.

18 Aug 2022

Highly sensitive DNA test identifies neuroborreliosis in horses

A Rutgers scientist aiming to help heal a sick horse created an ultra-sensitive DNA test that could have applications for difficult-to-detect illnesses in humans such as Lyme disease.

18 Aug 2022

New method helps identify which gut microbes most likely contribute to inflammatory diseases

Cedars-Sinai investigators have developed a method to help identify which human gut microbes are most likely to contribute to a slew of inflammatory diseases like obesity, liver disease, inflammatory bowel disease, cancer and some neurological diseases.

17 Aug 2022

The BCG vaccine against COVID-19 and other infectious diseases in type 1 diabetic adults

A recent article demonstrated that BCG vaccinations might offer a platform for protection against emerging SARS-CoV-2 variants and other pathogenic infections in type 1 diabetics.

17 Aug 2022

Antibody News and Research

Further Reading

How could SARS-CoV-2 viral infection modulate the immune landscape during the active infection phase and recovery in pregnant females?

The safety, tolerability, and pharmacokinetics of a muco-trapping monoclonal antibody delivered by inhalation

Updated guidelines on the Valneva SARS-CoV-2 vaccine

Epistasis leads to the reduction in genetic barrier to COVID-19 neutralizing antibody escape

DNA origami as an alternative platform to display the RBD of SARS-CoV-2

What risk factors are associated with post-acute sequelae of SARS-CoV-2?

What are the effects of anti-spike antibody levels on SARS-CoV-2 infection risk?

The role of SARS-CoV-2 in COVID-19-associated chilblains

Many people infected with SARS-CoV-2 Omicron didn't realize it

Study reveals safety and uptake of sotrovimab against severe SARS-CoV-2 infection in England

How effective are nanotechnology-based vaccines, drugs, and antibodies to combat variants of SARS-CoV-2?

Study shows rapid waning of immune protection due to prior BA.1/BA.2 infection against BA.5 breakthrough infection

Durability of immune protection after booster immunization with COVID-19 adjuvanted subunit vaccine against the immune-evasive Omicron BA.1 variant

How natural alterations inside the SARS-CoV-2 glycan barrier affect spike protein dynamics

Human antibody responses to SARS-CoV-2 infection after two years

Researchers investigate human monkeypox infection without sexual exposure or viral prodrome

How do BNT162b2 vaccine-induced neutralizing and non-neutralizing antibodies synergize to promote protection against SARS-CoV-2?

Highly sensitive DNA test identifies neuroborreliosis in horses

New method helps identify which gut microbes most likely contribute to inflammatory diseases

The BCG vaccine against COVID-19 and other infectious diseases in type 1 diabetic adults

Antibodies eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo